• March 10, 2015
• Drugs

FDA Approves Opdivo for Advanced Melanoma

The U.S. Food and Drug Administration today granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who no longer respond to other drugs. Read press release 

Click to read Opdivo Announcement

For more information Opdivo